Translational Oncology

Article	Citations
ERβ-regulated circATP2B1/miR-204–3p/TWIST1 positive feedback loop facilitates epithelial to mesenchymal transition in clear cell renal cell carcinoma	226
Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer	123
Radiation from frequent whole-body CT scans induces systemic immunosuppression and immune activation of tumor tissue	117
LncRNA DGUOK-AS1 facilitates non-small cell lung cancer growth and metastasis through increasing TRPM7 stability via m6A modification	106
Predictive value of peripheral blood leukocytes-based methylation of Long non-coding RNA MALAT1 and H19 in the chemotherapy effect and prognosis of gastric cancer	98
Integrated multi-omics demonstrates enhanced antitumor efficacy of donafenib combined with FADS2 inhibition in hepatocellular carcinoma	87
The Potential Role of C4 MYH11+ Fibroblasts and the MDK-SDC2 Ligand-Receptor Pair in Lung Adenocarcinoma: Implications for Prognosis and Therapeutic Strategies	76
A Novel Epigenetic Strategy to Concurrently Block Immune Checkpoints PD-1/PD-L1 and CD155/TIGIT in Hepatocellular Carcinoma	72
CD44 occurring alternative splicing promotes cisplatin resistance and evokes tumor immune response in oral squamous cell carcinoma cells	63
Identification of IMPA2 as the hub gene associated with colorectal cancer and liver metastasis by integrated bioinformatics analysis	62
A novel telomerase-derived peptide GV1001-mediated inhibition of angiogenesis: Regulation of VEGF/VEGFR-2 signaling pathways	61
Investigating the molecular mechanisms and clinical potential of APO+ endothelial cells associated with PANoptosis in the tumor microenvironment of hepatocellular carcinoma using single-cell sequencin	60
The double face of cold in cancer	60
Corrigendum to “Genomic profiles and their relationships with clinical characteristics and immune features in cervical cancer” [Translational Oncology 44 (2024) 1–10/101923]	54
HDAC inhibitor (SAHA) enhances B7-H3-specific CAR T cell cytotoxic efficacy against chondrosarcoma cells and prolongs survival in an orthotopic mouse model	51
Predicting lymphoma prognosis using machine learning-based genes associated with lactylation	50
CD38 overexpression drives glioblastoma progression via L1CAM/ICAM1/JAK-STAT-Driven tumor microenvironment rewiring	48
miR-1182-mediated ALDH3A2 inhibition affects lipid metabolism and progression in ccRCC by activating the PI3K-AKT pathway	47
Development of a single-cell derived MDSCs signature score for prognostic risk stratification and therapeutic decision guidance in breast cancer	47
Pan-cancer analysis of super-enhancer-induced LINC00862 and validation as a SIRT1-promoting factor in cervical cancer and gastric cancer	46
Connexin43 is associated with the progression of clear cell renal carcinoma and is regulated by tangeretin to sygergize with tyrosine kinase inhibitors	45
Association of PIK3CA mutation with outcomes in HER2-positive breast cancer treated with anti-HER2 therapy: A meta-analysis and bioinformatic analysis of TCGA‑BRCA data	43
ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinoma	41
FUBP1 in human cancer: Characteristics, functions, and potential applications	40
Hypericin mediated photodynamic therapy induces ferroptosis via inhibiting the AKT/mTORC1/GPX4 axis in cholangiocarcinoma	38

Clinical characteristics and treatment efficacy of immune checkpoint inhibitors (ICIs) in patients with ICIs-induced Adrenal insufficiency	38
Loss of p53 epigenetically modulates epithelial to mesenchymal transition in colorectal cancer	38
Integrative multi-omics analysis identifies key ubiquitination regulators in prostate cancer	38
USP52 promotes clear cell renal carcinoma progression by deubiquitinating and stabilizing CORO6	37
XIAP overexpressing inflammatory breast cancer patients have high infiltration of immunosuppressive subsets and increased TNFR1 signaling targetable with Birinapant	36
GSDME has prognostic and immunotherapeutic significance in residual hepatocellular carcinoma after insufficient radiofrequency ablation	36
Commentary: Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in cholangiocarcinoma	36
Anti-PD-1/PD-L1 therapy for colorectal cancer: Clinical implications and future considerations	36
NKp44-based chimeric antigen receptor effectively redirects primary T cells against synovial sarcoma	34
Exploration of the mechanism of 5-Methylcytosine promoting the progression of hepatocellular carcinoma	33
E2F2 serves as an essential prognostic biomarker and therapeutic target for human renal cell carcinoma by presenting “E2F2/miR-16–5p/SPTLC1” schema	32
Acetophenone protection against cisplatin-induced end-organ damage	32
Glutamine withdrawal leads to the preferential activation of lipid metabolism in metastatic colorectal cancer	32
CT radiomics combined with clinical variables for predicting the overall survival of hepatocellular carcinoma patients after hepatectomy	32
CDYL loss promotes cervical cancer aggression by increasing PD-L1 expression via the suppression of IRF2BP2 transcription	32
Liposomal sodium clodronate mitigates radiation-induced lung injury through macrophage depletion	31
Multiphase enhanced CT-based transformer for differential diagnosis and predicting surgical risk events of solid abdominal tumors in children	31
Assessment of targeted therapy opportunities in sinonasal cancers using patient-derived functional tumor models	31
Nanoscale biomaterials for terahertz imaging: A non-invasive approach for early cancer detection	31
Semaphorin 6D as an independent predictor for better prognosis in clear cell renal cell carcinoma	30
Nuclear protein in testis carcinoma of the lung	30
Combining Mitomycin C with inhibition of BAD phosphorylation enhances apoptotic cell death in advanced cervical cancer	30
Matrix stiffness induces an invasive-dormant subpopulation via cGAS-STING axis in oral cancer	30
A Glycerophospholipid Metabolism-Based Prognostic Model Guides Osteosarcoma Therapy	29
Penfluridol enhances anti-tumor immunity in colorectal cancer by inducing proteasome-mediated degradation of PD-L1 via the activation of AMPK	29
PRRX2 predicts poor survival prognosis, and promotes malignant phenotype of lung adenocarcinoma via transcriptional activates PSMD1	29
Parathyroid hormone related protein (PTHrP) in patients with pancreatic carcinoma and overt signs of disease progression and host tissue wasting	29
Single-cell insights into HNSCC tumor heterogeneity and programmed cell death pathways	29
MAZ-mediated tumor progression and immune evasion in hormone receptor-positive breast cancer: Targeting tumor microenvironment and PCLAF+ subtype-specific therapy	28
A multi-institutional observational study evaluating the incidence and the clinicopathological characteristics of NeoRAS wild-type metastatic colorectal cancer	26
Construction and validation of golgi apparatus-related genes as predictors of the immune microenvironment and prognosis in colorectal cancer	26
Amivantamab and Mobocertinib in Exon 20 insertions EGFR Mutant Lung Cancer, Challenge To The Current Guidelines	25
Intratumoral heterogeneity after targeted therapy in murine cancer models with differing degrees of malignancy	25
Low expression of ZHX3 is associated with progression and poor prognosis in colorectal cancer	25
Prognostication of colorectal cancer liver metastasis by CE-based radiomics and machine learning	25
Retinol-binding protein 4 as a promising serum biomarker for the diagnosis and prognosis of hepatocellular Carcinoma	25
YTHDF2 regulates the adriamycin (ADM) resistance in NKTCL by modulating the m6A modification of SLC16A9	25
Graphene therapy-related lncRNAs as prognostic and immune microenvironmental biomarkers in hepatocellular carcinoma	25
Currents status of radiotracers for breast cancer imaging in PET	25
Systemic immune-inflammation index predicts survival in patients with resected lung invasive mucinous adenocarcinoma	25
Individualized prognosis stratification in muscle invasive bladder cancer: A pairwise TP53-derived transcriptome signature	24
CKAP4-mediated activation of FOXM1 via phosphorylation pathways regulates malignant behavior of glioblastoma cells	24
Comprehensive investigation in oncogenic functions and immunological roles of NCBP2 and its validation in prostate cancer	24
HIF1A predicts the efficacy of anti-PD-1 therapy in advanced clear cell renal cell carcinoma	24
Expression of MASTL (Greatwall) associates with good prognosis and response to radiotherapy in pharyngeal squamous cell carcinoma	24
A monoclonal antibody targeting B7-H3 in human embryonic stem cells exhibits anti-tumor activity in hepatocellular carcinoma xenografts	24
Improved survival of patients with stage III small-cell lung cancer with primary resection: A SEER-based analysis	24
M2-like tumor-associated macrophages may promote tumor progression in malignant pleural mesothelioma	24
Identification of leucine-rich repeat-containing protein 59 (LRRC59) located in the endoplasmic reticulum as a novel prognostic factor for urothelial carcinoma	24
RIPK2 and lysosomal pathway: Unveiling a new mechanism for lung cancer metastasis	23

Combined anti-leukemic effect of gilteritinib and GSK-J4 in FLT3-ITD+ acute myeloid leukemia	23
Fractionated radiation therapy alters energy metabolism and induces cellular quiescence exit in patient-derived orthotopic xenograft models of high-grade glioma	23
A pan-cancer landscape of centromere proteins in tumorigenesis and anticancer drug sensitivity	23
Evolution of conditioning regimens prior to autologous stem cell transplantation in lymphoma patients	23
Genomic landscape of pleural mesothelioma in Japanese patients: A comprehensive analysis using nationwide database	23
Aberrant overexpression of m6A writer and reader genes in pediatric B-Cell Acute Lymphoblastic Leukemia (B-ALL)	23
LncRNA TCL6 regulates miR-876–5p/MYL2 axis to suppress breast cancer progression	22
ENO1 promotes PDAC progression by inhibiting CD8+ T cell infiltration through upregulating PD-L1 expression via HIF-1α signaling	22
Integration of OV6 expression and CD68+ tumor-associated macrophages with clinical features better predicts the prognosis of patients with hepatocellular carcinoma	22
The need for research targeting the link between occupational carcinogens and hepatopancreatobiliary cancers in Africa: A systematic review	22
Targeting transcriptional kinase of CDK7 halts proliferation of multiple myeloma cells by modulating the function of canonical NF-kB pathway and cell cycle regulatory proteins	22
Targeting sinonasal undifferentiated carcinoma with a combinatory immunotherapy approach	21
Single-cell RNA sequencing integrated with bulk RNA sequencing analysis of clock circadian regulator with prognostic and immune microenvironment in thyroid cancer	21
Tumor-stroma contact ratio - a novel predictive factor for tumor response to chemoradiotherapy in locally advanced oropharyngeal cancer	21
HSP90AA1 is an unfavorable prognostic factor for hepatocellular carcinoma and contributes to tumorigenesis and chemotherapy resistance	21
Beyond first-line therapy: efficacy and safety outcomes of continuing immunotherapy in extensive stage small cell lung cancer after PD-L1 inhibitor progression	21
Targeting FASN enhances cisplatin sensitivity via SLC7A11-mediated ferroptosis in cervical cancer	21
Utility of 18F-FDG uptake in predicting major pathological response to neoadjuvant immunotherapy in patients with resectable non‑small cell lung cancer	21
A clinical study on the efficacy of concurrent chemoradiotherapy combined with targeted therapy and hyperthermia in patients with locally advanced cervical cancer	21
Dissecting incidence and mortality inequalities of six types of liver diseases in 39 alcohol-dominant countries and 93 virus-dominant countries under the aging context: Insights from the Global Burden	21
Hub genes in adenocarcinoma of the esophagogastric junction based on weighted gene co-expression network analysis and immunohistochemistry	21
Uncarboxylated osteocalcin induced miR-143-3p targets SP7 and activates PI3K/Akt signaling in TNBC cells to promote invasion and migration	21
High-resolution anoscopy predictive modeling of anal canal cancer response after definitive chemoradiotherapy in COVID19 era	20
Cancer is not a guest	20
INHA acts as a novel and potential biomarker in lung adenocarcinoma and shapes the immune-suppressive tumor microenvironment	20
Patient-derived tumor organoids: A preclinical platform for personalized cancer therapy	20
The relationship between URG4 and clinicopathologic parameters and its effect on two-year survival in gastric carcinoma	20
Generation of a competing endogenous RNA network and validation of BNIP1 expression in the lung of irradiated mice	20
Nuclear factor E2 p45-related factor (NRF2) and peroxiredoxin 6 tissular expression as prognostic biomarkers for advanced HPV-negative squamous cell carcinoma of the oropharynx	19
GTF2H5 Identified as a crucial synthetic lethal target to counteract chemoresistance in colorectal cancer	19
Low levels of miR-34c in nasal washings as a candidate marker of aggressive disease in wood and leather exposed workers with sinonasal intestinal-type adenocarcinomas (ITACs)	19
Discovering the Potential Role of the C2 DUSP2+ MCs Subgroup in Lung Adenocarcinoma	19
NPRA promotes fatty acid metabolism and proliferation of gastric cancer cells by binding to PPARα	19
Propofol inhibits glioma growth by blocking the formation of the NF-κB/LGI4 feedback loop to activate TP53 self-transcription	19
Machine-learning based integrating bulk and single-cell RNA sequencing reveals the SLC38A5-CCL5 signaling as a promising target for clear cell renal cell carcinoma treatment	19
Circular RNA 0010117 promotes aggressive glioblastoma behavior by regulating the miRNA-6779-5p/SPEN axis	19
Pan-cancer analysis of 60S Ribosomal Protein L7-Like 1 (RPL7L1) and validation in liver hepatocellular carcinoma	18
Peroxisome proliferator-activated receptors: Key regulators of tumor progression and growth	18
Multi-omics profiling to identify early plasma biomarkers in pre-diagnostic pancreatic ductal adenocarcinoma: a nested case-control study	18
RNA-binding protein IGF2BP2 suppresses metastasis of clear cell renal cell carcinoma by enhancing CKB mRNA stability and expression	18
Patient reported change in pain outcome among stage IV cancer patients with bone metastases following palliative radiotherapy: A prospective study from Ethiopia	18
Cardiotoxicity of breast cancer drug treatments	18
Personalized and HPV cancer vaccines in head and neck squamous cell carcinoma: from concept to clinical implementation	18
PER3 suppresses tumor metastasis of oral squamous cell carcinoma by promoting HIF-1α degradation	18
TRIM37 promotes gallbladder cancer proliferation by activating the Wnt/β-catenin pathway via ubiquitination of Axin1	18
LncRNA PSMB8-AS1 increases glioma malignancy via the miR-382-3p/BCAT1 axis	18
Progress on carbon dots and hydroxyapatite based biocompatible luminescent nanomaterials for cancer theranostics	18
Extracellular vesicles as biomarkers for endometrial cancer – A systematic review	18
Contribution of immune cells in synergistic anti-tumor effect of ablation and immunotherapy	17
Myoepithelial carcinoma of major salivary glands: Analysis of population-based clinicopathologic and prognostic features	17
IL1RA inhibits the progression of oral squamous cell carcinoma by mediating type Ⅰ interferon response	17
Bmi-1 inhibition sensitizes head and neck cancer stem cells to cytotoxic chemotherapy	17
lncRNA JPX modulates malignant progress of osteosarcoma through targeting miR-33a-5p and PNMA1 regulatory loop	17
Spatial correlation between in vivo imaging and immunohistochemical biomarkers: A methodological study	17
Radiosensitizing effects of CDK4/6 inhibitors in hormone receptor-positive and HER2-negative breast cancer mediated downregulation of DNA repair mechanism and NF-κB-signaling pathway	17
Exosomal circ50547 as a potential marker and promotor of gastric cancer progression via miR-217/HNF1B axis	17
A retrospective cohort study of neoadjuvant chemoradiotherapy combined with immune checkpoint inhibitors in locally advanced rectal cancer	17
Corrigendum to < Rapid evaluation of T cell clonality in the diagnostic work-up of mature T cell neoplasms: TRBC1-based flow cytometric assay experience><Translational Oncology, 26C (2022) 10	17
Enhanced effect of radiofrequency ablation on HCC by siRNA-PD-L1-endostatin Co-expression plasmid delivered	17
Development of a translational radiobiology platform using pancreatic cancer patient-derived organoids for personalized radiation oncology	17
A macrophage co-expression signature enables robust prognostic prediction in glioblastoma	17
Enhancement of Prognostic Outcomes in Stage III Non-Small Cell Lung Cancer: A Retrospective Study on Neoadjuvant Immuno-Chemotherapy Followed by Definitive Chemo-Radiotherapy	17
Evaluation of the 1021-HRD assay compared to established HRD testing platforms in ovarian cancer	17
Lipid metabolism of clear cell renal cell carcinoma predicts survival and affects intratumoral CD8 T cells	17
Design of a humanized CD40 agonist antibody with specific properties using AlphaFold2 and development of an anti-PD-L1/CD40 bispecific antibody for cancer immunotherapy	17
Yi Shen Tiao Gan decoction alleviates aromatase inhibitor–related bone loss by promoting H-type vessel formation	16
Immune-pyroptosis-related genes predict the prognosis of kidney renal clear cell carcinoma	16
LCMT1 indicates poor prognosis and is essential for cell proliferation in hepatocellular carcinoma	16
SNHG7 interacts with PCBP2 to promote CDKN2A expression and modulate cuproptosis in colorectal cancer	16
Long non-coding RNA FENDRR suppresses cancer-associated fibroblasts and serves as a prognostic indicator in colorectal cancer	16
WISP1 is the stromal-secreting oncoprotein via paracrine downregulation of NDRG1, KAI1, and Maspin in human bladder cancer cells	16
A mini-review-cancer energy reprogramming on drug resistance and immune response	16
Downregulation of PIP4K2C inhibits the breast cancer cell proliferation, migration and invasion	16
Timp2 loss-of-function mutation and TIMP2 treatment in a murine model of NSCLC: Modulation of immunosuppression and oncogenic signaling	16
Identification of novel prognostic indicators for oral squamous cell carcinoma based on proteomics and metabolomics	16
Transcriptional regulation of DLGAP5 by AR suppresses p53 signaling and inhibits CD8+ T cell infiltration in triple-negative breast cancer	16
Establishment and characterization of preclinical models of human gynecologic tract carcinosarcomas demonstrates targetable FGFR1 alterations	16
Mechanistic and translational insights into plant-derived natural products in preclinical multiple myeloma research: Current evidence	16
Characterization of the mechanism of Scutellaria baicalensis on reversing radio-resistance in colorectal cancer	16
Identification and validation of a prognostic risk model based on radiosensitivity-related genes in nasopharyngeal carcinoma	16

Integration RNA bulk and single cell RNA sequencing to explore the change of glycolysis-related immune microenvironment and construct prognostic signature in head and neck squamous cell carcinoma	16
Development and validation of a microenvironment-related prognostic model for hepatocellular carcinoma patients based on histone deacetylase family	16
Exploring the tumor-suppressive role of miRNA-200c in head and neck squamous cell carcinoma: Potential and mechanisms of exosome-mediated delivery for therapeutic applications	16
Individualized tumor-reactive T cells exhibit a potent anti-tumor response in prostate cancer	16
Development and validation of a prognostic and drug sensitivity model for gastric cancer utilizing telomere-related genes	16
Dysregulation of peripheral and intratumoral KLRG1+ CD8+ T cells is associated with immune evasion in patients with non-small-cell lung cancer	16
The new Bruton’s tyrosine kinase inhibitors SPA8007 and SPA8009 reduce stemness and invasiveness of patient-derived glioblastoma tumorspheres	16
Development and validation of a radiomic prediction model for TACC3 expression and prognosis in non-small cell lung cancer using contrast-enhanced CT imaging	15
Micro-hydrogel injectables that deliver effective CAR-T immunotherapy against 3D solid tumor spheroids	15
PIS as a regulator of cellular heterogeneity, prognostic significance, and immune landscape in thyroid cancer	15
A high-quality model for predicting the prognosis of breast neuroendocrine carcinoma to help clinicians decide on appropriate treatment methods: A population-based analysis	15
Understanding the heterogeneity of pancreatic ductal adenocarcinoma	15
Specific vaginal and gut microbiome and the anti-tumor effect of butyrate in cervical cancer women	15
Response Gene to Complement 32 is associated with poor patient survival and an inflamed tumor-immune microenvironment in clear cell renal cell carcinoma	15
The PI3K pathway is a downstream effector of NRF2 activation in the esophagus	15
Comprehensive characterization of immune landscape of Indian and Western triple negative breast cancers	15
Increased tumor-infiltrating plasmacytoid dendritic cells express high levels of PD-L2 and affect CD8+ T lymphocyte infiltration in human laryngeal squamous cell carcinoma	15
Sitravatinib combined with venetoclax exerts effective synergy to eliminate acute myeloid leukemia cells with FLT3-ITD mutations	15
Dual inhibition of BET and EP300 has antitumor activity in undifferentiated pleomorphic sarcomas and synergizes with ferroptosis induction	15
Recommendations for extracellular vesicle miRNA biomarker research in the endometrial cancer context	15
Charting new frontiers: Co-inhibitory immune checkpoint proteins in therapeutics, biomarkers, and drug delivery systems in cancer care	14
ARID1A deficiency associated with MMR deficiency and a high abundance of tumor-infiltrating lymphocytes predicts a good prognosis of endometrial carcinoma	14
Early onset pancreatic cancer: A review	14
RPS21 Enhances hepatocellular carcinoma development through GPX4 stabilization	14
CCR9-CCL25 mediated plasmacytoid dendritic cell homing and contributed the immunosuppressive microenvironment in gastric cancer	14
Camizestrant causes reversible pharmacological effects on retinal responses in rats	14
Integrative multi-omics of matched primary and liver metastatic colorectal cancer organoids identifies putative molecular targets	14
Genomic profiles and their relationships with clinical characteristics and immune features in cervical cancer	14
Circ-0008536 inhibits doxorubicin resistance in triple-negative breast cancer via the miR-382-5p/GGNBP2 axis	14
Galectin-7 as a biomarker for aggressiveness and poor prognosis in thymic epithelial tumors	14
miRNA patterns in male LUSC patients - the 3-way mirror: Tissue, plasma and exosomes	14
RBM15 facilities lung adenocarcinoma cell progression by regulating RASSF8 stability through N6 Methyladenosine modification	14
MiR-193b-3p and miR-132-3p as prognostic biomarkers of survival in pleural mesothelioma patients treated with first-line bevacizumab plus pemetrexed-platinum chemotherapy in the IFCT-0701 MAPS phase 3	14
Analysis of transition metal content in glioblastoma reveals association between iron and survival	14
The molecular mechanism and challenge of targeting XPO1 in treatment of relapsed and refractory myeloma	14
The predictive efficacy of tumor mutation burden in immunotherapy across multiple cancer types: A meta-analysis and bioinformatics analysis	14
The ATR inhibitor VE-821 increases the sensitivity of gastric cancer cells to cisplatin	14
Exosomal mRNA Cargo are biomarkers of tumor and immune cell populations in pediatric osteosarcoma	14
Distinctive mesenchymal-like neurofibroma stem cells shape NF1 clinical phenotypes controlled by BDNF microenvironment	14
Tebentafusp in first-line melanoma trials: An outperforming outlier	14
Ferroptosis induction enhances anti-PD-1 efficacy in NSCLC via HIF-1α/PD-L1 modulation	13
Genomic profile helps to predict the clonal evolution and outcome of BCR-ABL-negative myeloproliferative neoplasms	13
HER2 as a potential therapeutic target on quiescent prostate cancer cells	13
A comprehensive review on recent advances in exosome isolation and characterization: Toward clinical applications	13
Nutritional strategies against skeletal muscle wasting in cancer-associated cachexia: the role of β-hydroxybutyrate and polyunsaturated fatty acids	13
Resonance of fatty acid metabolism and immune infiltration in anti-PD-1 monotherapy for breast cancer	13
MUC16 promotes endometrial cancer progression and modulates sensitivity to lapatinib through the ESR1/PI3K/AKT axis	13
Comprehensive analysis of protein post-translational modifications reveals PTPN2-STAT1-AOX axis-mediated tumor progression in hepatocellular carcinomas	13
RPL36A activates ERK pathway and promotes colorectal cancer growth	13
Diversity and inclusivity in oncology: A narrative review and orientation for institutional measures in Germany	13
Anti-epidermal growth factor receptor (EGFR) monoclonal antibody combined with chemoradiotherapy for induction chemotherapy resistant locally advanced nasopharyngeal carcinoma: A prospective phase II	13
Tissue contexture determines the pattern and density of tumor-infiltrating immune cells in HPV-associated squamous cell carcinomas of oropharynx and uterine cervix	13
Comprehensive assessment of serum 3′-tRFArg as a novel diagnostic biomarker for gastric cancer	13
Predicting oncogene mutations of lung cancer using deep learning and histopathologic features on whole-slide images	13
MAZ-Mediated ubiquitin-conjugating enzyme E2C upregulation promotes breast cancer progression via the MAPK signaling pathway	13
Saliva as a potential non-invasive liquid biopsy for early and easy diagnosis/prognosis of head and neck cancer	13
Preclinical evidence for employing MEK inhibition in NRAS mutated pediatric gastroenteropancreatic neuroendocrine-like tumors	12
KIAA1529 regulates RAD51 expression to confer PARP inhibitors resistance in ovarian cancer	12
Clinical characteristics of EGFR-ctDNA shedders in EGFR-mutant NSCLC patients	12
A practical distribution pattern of α-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patients with pancreatic ductal adenocarcinoma	12
Application of predictive model based on CT radiomics and machine learning in diagnosis for occult locally advanced esophageal squamous cell carcinoma before treatment: A two-center study	12
Long noncoding RNA BBOX1-AS1 increased radiotherapy sensitivity in colorectal cancer by stabilizing and activating PFK1	12
Fam198b as a novel biomarker for gastric cancer and a potential therapeutic target to prevent tumor cell proliferation dysregulation	12
NDUFS8 facilitates hepatocellular carcinoma growth by enhancing mitochondrial function and escaping HUWE1-dependent degradation	12
Analysis of patient reported outcomes included in the registrational clinical trials of nivolumab for advanced non-small cell lung cancer	12
Suppression of FAM83D Inhibits Glioma Proliferation, Invasion and Migration by Regulating the AKT/mTOR Signaling Pathway	12
Multi-omics analysis of NET+ TAN explains the immunosuppressive TME and prognosis value of malignant clinical characteristics in TNBC	12
Development and validation of prognostic nomograms based on peripheral blood T-cell counts and their dynamic changes for patients with nasopharyngeal carcinoma receiving radiotherapy	12
A prognostic signature consisting of N6-methyladenosine modified mRNAs demonstrates clinical potential in prediction of biochemical recurrence and guidance on precision therapy in prostate cancer	12
Role of 3-mercaptopyruvate sulfurtransferase in cancer: Molecular mechanisms and therapeutic perspectives	12
Hypoxia induced cell dormancy of salivary adenoid cystic carcinoma through miR-922/DEC2 axis	12
SnoRNA U50A mediates everolimus resistance in breast cancer through mTOR downregulation	12
Long noncoding RNAs and HPV-related cervical cancer: Uncovering molecular mechanisms and clinical applications	12
Core regulatory mechanisms of the PD-L1 axis and clinical strategies for immune escape and immunotherapy response in nasopharyngeal carcinoma	12
Corrigendum to “Exosomes in malignant pleural effusion from lung cancer patients impaired the cytotoxicity of double-negative T cells” [Translational Oncology 27 (2023) 1–9/101564]	12
Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: A systematic literature review	12
Clinical application of the 21-gene oncotype recurrence score in an older cohort: A single center experience	12
NLRC5 potentiates anti-tumor CD8+ T cells responses by activating interferon-β in endometrial cancer	12
Functional temozolomide sensitivity testing of patient-specific glioblastoma stem cell cultures is predictive of clinical outcome	12
CDK4/6 inhibitors promote PARP1 degradation and synergize with PARP inhibitors in non-small cell lung cancer	12
APOA1 promotes tumor proliferation and migration and may be a potential pan-cancer biomarker and immunotherapy target	12
PTBP3 promotes tumorigenesis of glioblastoma by stabilizing Twist1	12
Shaping the future one slice at a time: How 3D organotypic tumour slice models are driving drug discovery in ovarian cancer	12
Utilization of machine learning algorithms for the identification of the RLN associated prognostic model and feature biomarkers of RLN-related subtypes in breast cancer	12
Ad-VT causes ovarian cancer A2780 cell death via mitochondrial apoptosis and autophagy pathways	12
A role for androgen receptor variant 7 in sensitivity to therapy: Involvement of IGFBP-2 and FOXA1	12
EGFR mutation testing from pleural effusions of non-small cell lung cancer patients at the institute for oncology and radiology of Serbia	12
Lithium chloride induces apoptosis by activating endoplasmic reticulum stress in pancreatic cancer	12
Integrated spatial and single‑cell transcriptomics maps disulfidptosis in renal cell carcinoma and reveals PDLIM1 as a prognostic biomarker and potential therapeutic target	12
PRMT5 inhibitors: Therapeutic potential in pancreatic cancer	12
Ra-223 induces clustered DNA damage and inhibits cell survival in several prostate cancer cell lines	12
Enhancing chemotherapy response prediction via matched colorectal tumor-organoid gene expression analysis and network-based biomarker selection	12
Non-genetic heterogeneity and immune subtyping in breast cancer: Implications for immunotherapy and targeted therapeutics	11
CT-guided high dose rate brachytherapy can induce multiple systemic proteins of proliferation and angiogenesis predicting outcome in HCC	11
Thiostrepton suppresses intrahepatic cholangiocarcinoma progression via FOXM1-mediated tumor-associated macrophages reprogramming	11